X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-14 | AARD | Aardvark Therapeutics, Inc. | Lee Tien-Li | CEO, 10% | P - Purchase | $16.00 | +16,542 | 2,970,203 | +1% | +$264,672 | |||||
2025-02-18 | ZBIO | Zenas Biopharma, Inc. | Moulder Leon O Jr | CEO | P - Purchase | $6.67 | +25,000 | 1,938,194 | +1% | +$166,750 | ||||||
| D | 2025-02-14 | AARD | Aardvark Therapeutics, Inc. | Sun Nelson | CFO | P - Purchase | $16.00 | +10,000 | 99,484 | +11% | +$160,000 | |||||
2025-02-18 | LLIAX | Lord Abbett Flexible Income Fund | Picciotto Mary Ann | Chief Compliance Officer | P - Purchase | $10.00 | +10,000 | 10,000 | New | +$100,000 | ||||||
2025-02-18 | LLIAX | Lord Abbett Flexible Income Fund | Fapohunda Brooke | GC | P - Purchase | $10.00 | +10,000 | 10,000 | New | +$100,000 | ||||||
2025-02-14 | BMY | Bristol Myers Squibb Co | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | P - Purchase | $54.84 | +1,823 | 63,932 | +3% | +$100,000 | ||||||
2025-02-19 | XFLT | Xai Octagon Floating Rate & Alternative Income Trust | Spence John Yogi | VP | P - Purchase | $6.41 | +3,000 | 581,834 | +1% | +$19,229 | ||||||
2025-02-19 | RCEL | Avita Medical, Inc. | O'Toole David D | CFO | P - Purchase | $10.25 | +1,000 | 24,734 | +4% | +$10,250 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |